Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220006117 220002378 1.72 56.4 Disease modification (D) 2015-09-02 2015-09-02 AML 19 TRIAL 1 N 220029650 AML19 TRIAL
220006118 220011336 0 0 Curative (C) 2018-09-08 2018-09-08 Nilotinib N N 220029651 NILOTINIB
220006119 220002379 1.57 null Disease modification (D) 2017-06-07 2017-06-22 Nilotinib N N 220029652 NILOTINIB
220006120 220011337 1.57 61.4 Curative (C) 2016-06-10 2016-06-10 AML 19 TRIAL Y N 220029657 AML19 TRIAL
220006121 220011337 1.67 83.7 Curative (C) 2016-06-26 2016-06-30 AML 19 TRIAL 01 null 220029657 AML19 TRIAL
220006122 220011337 1.7 81.8 Disease modification (D) 2017-07-31 2017-09-13 FLAG + Idarubicin N N 220029657 FLAG + IDARUBICIN
220006123 220002380 1.78 50 Curative (C) 2014-03-21 2014-03-23 FBC Conditionining 1 N 220029662 NOT MATCHED
220006124 220002380 1.79 81.6 Curative (C) 2015-03-27 2015-03-27 AML 19 TRIAL null null 220029662 AML19 TRIAL
220006125 220002380 0 79 Curative (C) 2013-03-25 2013-06-20 Nilotinib N N 220029662 NILOTINIB
220006126 220002381 null 73.15 Neo-adjuvant (N) 2016-06-13 2016-06-13 APML Consolidation II ATRA,Idarubicin 1 N 220029666 NOT MATCHED
220006127 220002381 null null Disease modification (D) 2013-06-20 2013-06-20 Nilotinib N N 220029666 NILOTINIB
220006128 220002382 null 0 Curative (C) 2017-01-18 2017-01-18 Amsacrine + ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT) + BUSULFAN + CYTARABINE + FLUDARABINE null null 220029668 NOT MATCHED
220006129 220002382 1.6 72.1 Curative (C) 2014-05-17 2014-05-18 FLAG + Idarubicin N N 220029668 FLAG + IDARUBICIN
220006130 220002382 1.74 103 Curative (C) 2017-01-16 2017-01-25 AML MyeChild 01 A Mitozantrone/Cytarabine Y N 220029668 NOT MATCHED
220006133 220002384 null 53.5 Neo-adjuvant (N) 2014-03-22 2014-03-30 Nilotinib N null 220029677 NILOTINIB
220006134 220002384 null 78 Disease modification (D) 2015-06-16 2015-06-19 Nilotinib 2 N 220029677 NILOTINIB
220006135 220002384 1.61 79 Curative (C) 2017-04-23 2017-04-23 AML 19 TRIAL 01 null 220029677 AML19 TRIAL
220006136 220002385 1.49 0 Palliative (P) 2017-11-07 2017-11-12 Nilotinib 02 N 220029685 NILOTINIB
220006137 220002385 null 33.9 Neo-adjuvant (N) 2016-11-09 2016-11-12 AML MyeChild N N 220029685 NOT MATCHED
220006138 220002385 1.72 101 Curative (C) 2017-06-14 2017-06-14 FLAG + Idarubicin 02 null 220029685 FLAG + IDARUBICIN
220006139 220002385 null 0 Disease modification (D) 2014-06-24 2014-06-24 Nilotinib N N 220029685 NILOTINIB
220006140 220002385 1.72 79.3 Curative (C) 2014-04-09 2014-04-09 FLAG + Idarubicin N N 220029685 FLAG + IDARUBICIN
220006141 220002385 1.58 75 Curative (C) null 2015-04-29 FLAG + Idarubicin Y N 220029685 FLAG + IDARUBICIN
220006142 220002386 null 61 Curative (C) 2017-08-18 2017-08-20 FLAG + Idarubicin N N 220029701 FLAG + IDARUBICIN
220006145 220016090 0 79 Palliative (P) 2016-11-11 2016-11-30 Nilotinib 2 N 220029705 NILOTINIB
220006146 220016090 null null Palliative (P) 2014-04-01 2014-04-02 Nilotinib N N 220029705 NILOTINIB
220006147 220002388 0 0 Palliative (P) 2015-04-03 2015-04-04 Nilotinib N N 220029708 NILOTINIB
220006148 220002388 1.64 null Disease modification (D) 2014-01-28 2014-01-31 Nilotinib 02 N 220029708 NILOTINIB
220006151 220002390 0 63 Curative (C) 2017-09-04 2017-09-04 Nilotinib N N 220029715 NILOTINIB
220006152 220002390 0 0 Disease modification (D) 2014-03-10 2014-03-10 Nilotinib null N 220029715 NILOTINIB
220006153 220002390 0 0 Disease modification (D) 2014-07-09 2014-07-11 Nilotinib N N 220029715 NILOTINIB
220006161 220002393 null null Palliative (P) null 2016-10-16 AML Interim Guidelines FLAG-Ida 02 N 220029739 FLAG + IDARUBICIN
220006162 220002394 null 63.8 null 2014-03-04 2014-03-05 FLAG + Idarubicin 01 N 220029740 FLAG + IDARUBICIN
220006163 220002394 1.67 80.2 Curative (C) 2014-11-26 2014-12-03 FLAG + Idarubicin 2 N 220029740 FLAG + IDARUBICIN
220006164 220002394 null 0 Curative (C) 2017-03-18 2017-03-28 Nilotinib N N 220029740 NILOTINIB
220006165 220002395 null 83.8 Neo-adjuvant (N) 2016-02-13 2016-02-13 Nilotinib N N 220029747 NILOTINIB
220006166 220002396 0 null Curative (C) null 2013-02-15 Nilotinib N N 220029749 NILOTINIB
220006167 220002396 null 83 Curative (C) 2013-07-11 2013-07-21 CML Dasatinib N N 220029749 NOT MATCHED
220006168 220002396 null null null 2014-01-24 2014-01-24 Nilotinib 02 N 220029749 NILOTINIB
220006169 220002396 1.61 76.3 Curative (C) 2018-01-09 2018-01-09 AML 19 TRIAL Y N 220029749 AML19 TRIAL
220006170 220002396 1.74 68.3 Curative (C) 2017-08-02 2017-08-04 AML 19 TRIAL 1 N 220029749 AML19 TRIAL
220006171 220002397 1.71 null null null 2014-11-06 FLAG + Idarubicin 02 N 220029756 FLAG + IDARUBICIN
220006172 220002398 1.9 0 Curative (C) 2014-10-20 2014-11-04 Nilotinib N N 220029760 NILOTINIB
220006175 220002400 1.87 72.1 Adjuvant (A) 2016-10-29 2016-10-29 FLAG + Idarubicin 2 N 220029766 FLAG + IDARUBICIN
220006176 220011353 0 98 Not known (9) 2014-07-13 2014-07-13 Nilotinib 02 N 220029768 NILOTINIB
220006177 220016096 1.68 6 Curative (C) null 2015-06-10 FLAG + Idarubicin N N 220029769 FLAG + IDARUBICIN
220006178 220016096 null 85 Disease modification (D) 2016-09-18 2016-09-18 Nilotinib N N 220029769 NILOTINIB
220006179 220016096 null 28.8 Curative (C) 2014-12-14 2014-12-15 Idarubicin + Tretinoin (Induction course) Y null 220029769 NOT MATCHED
220006180 220002401 null 60.4 Curative (C) 2014-09-03 2014-09-03 APML HR Ind ATO + ATRA Y N 220029772 NOT MATCHED
220006181 220011354 1.7 77.2 Curative (C) 2015-04-28 2015-04-28 FLAG + Idarubicin N N 220029773 FLAG + IDARUBICIN